Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Duke University School of Medicine, Durham, North Carolina (Dr Huesch; email@example.com); David Geffen School of Medicine, University of California, Los Angeles (Dr Ong); and School of Pharmacy, University of Southern California, Los Angeles (Dr Doctor).
To the Editor: In their Viewpoint, Dr Mets and colleagues1 proposed leveraging the data contained in low-dose non–contrast-enhanced chest computed tomography (CT) scans obtained for lung cancer screening to screen for cardiovascular disease (CVD). The authors acknowledged several conceptual (eg, false-positive findings and cost-effectiveness of the lung cancer screening) and operational difficulties (eg, lack of electrocardiography synchronization).
Huesch MD, Ong MK, Doctor JN. Evaluating Other Diseases With Computed Tomographic Screening for Lung Cancer. JAMA. 2013;309(7):655-656. doi:10.1001/jama.2012.157205